{
  "ticker": "REGN",
  "year": 2023,
  "quarter": 4,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 28,
  "transactions": [
    {
      "id": 214373,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2023-12-27",
      "transaction_shares": "2049",
      "transaction_price": "482.68",
      "transaction_type": "M",
      "shares_after_transaction": "3296"
    },
    {
      "id": 214403,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-12-27",
      "transaction_shares": "2448",
      "transaction_price": "856.71",
      "transaction_type": "S",
      "shares_after_transaction": "14372"
    },
    {
      "id": 214424,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-12-27",
      "transaction_shares": "750",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "22111"
    },
    {
      "id": 214467,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-12-21",
      "transaction_shares": "456",
      "transaction_price": "843.79",
      "transaction_type": "S",
      "shares_after_transaction": "18294"
    },
    {
      "id": 214345,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2023-12-13",
      "transaction_shares": "610",
      "transaction_price": "376.69",
      "transaction_type": "M",
      "shares_after_transaction": "1857"
    },
    {
      "id": 214337,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2023-12-12",
      "transaction_shares": "7657",
      "transaction_price": "856.71",
      "transaction_type": "F",
      "shares_after_transaction": "48306"
    },
    {
      "id": 214408,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-12-12",
      "transaction_shares": "2552",
      "transaction_price": "856.71",
      "transaction_type": "F",
      "shares_after_transaction": "18750"
    },
    {
      "id": 214415,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-12-12",
      "transaction_shares": "5105",
      "transaction_price": "856.71",
      "transaction_type": "F",
      "shares_after_transaction": "15336"
    },
    {
      "id": 214435,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-12-12",
      "transaction_shares": "6381",
      "transaction_price": "856.71",
      "transaction_type": "F",
      "shares_after_transaction": "21084"
    },
    {
      "id": 214388,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SCHLEIFER LEONARD S",
      "reporting_owner_cik": "0001218629",
      "reporting_owner_position": "Bd. Co-Chair, President & CEO",
      "transaction_date": "2023-12-11",
      "transaction_shares": "25155",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "387270"
    },
    {
      "id": 214393,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2023-12-11",
      "transaction_shares": "25155",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "765327"
    },
    {
      "id": 214343,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2023-12-08",
      "transaction_shares": "883",
      "transaction_price": "843.79",
      "transaction_type": "F",
      "shares_after_transaction": "58538"
    },
    {
      "id": 214350,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2023-12-08",
      "transaction_shares": "809",
      "transaction_price": "843.79",
      "transaction_type": "F",
      "shares_after_transaction": "51891"
    },
    {
      "id": 214370,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Van Plew Daniel P",
      "reporting_owner_cik": "0001411984",
      "reporting_owner_position": "EVP & General Mgr, Industrial",
      "transaction_date": "2023-12-08",
      "transaction_shares": "1108",
      "transaction_price": "843.79",
      "transaction_type": "F",
      "shares_after_transaction": "20400"
    },
    {
      "id": 214421,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2023-12-08",
      "transaction_shares": "474",
      "transaction_price": "843.79",
      "transaction_type": "F",
      "shares_after_transaction": "20468"
    },
    {
      "id": 214440,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2023-12-08",
      "transaction_shares": "1013",
      "transaction_price": "843.79",
      "transaction_type": "F",
      "shares_after_transaction": "30686"
    },
    {
      "id": 214458,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2023-12-08",
      "transaction_shares": "852",
      "transaction_price": "843.79",
      "transaction_type": "F",
      "shares_after_transaction": "28572"
    },
    {
      "id": 214459,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-12-08",
      "transaction_shares": "852",
      "transaction_price": "843.79",
      "transaction_type": "F",
      "shares_after_transaction": "18951"
    },
    {
      "id": 214367,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2023-12-04",
      "transaction_shares": "20000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "79421"
    },
    {
      "id": 214430,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-12-01",
      "transaction_shares": "1",
      "transaction_price": "809.03",
      "transaction_type": "S",
      "shares_after_transaction": "18546"
    },
    {
      "id": 214409,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "MURPHY ANDREW J",
      "reporting_owner_cik": "0001796226",
      "reporting_owner_position": "EVP Research",
      "transaction_date": "2023-11-13",
      "transaction_shares": "20000",
      "transaction_price": "270.43",
      "transaction_type": "M",
      "shares_after_transaction": "79421"
    },
    {
      "id": 214466,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "STAHL NEIL",
      "reporting_owner_cik": "0001226689",
      "reporting_owner_position": "EVP Research and Development",
      "transaction_date": "2023-11-10",
      "transaction_shares": "400",
      "transaction_price": "0.0",
      "transaction_type": "G",
      "shares_after_transaction": "52700"
    },
    {
      "id": 214462,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2023-11-07",
      "transaction_shares": "6",
      "transaction_price": "824.59",
      "transaction_type": "S",
      "shares_after_transaction": "18641"
    },
    {
      "id": 214433,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-11-01",
      "transaction_shares": "1000",
      "transaction_price": "381.4",
      "transaction_type": "M",
      "shares_after_transaction": "20803"
    },
    {
      "id": 160211,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-13",
      "transaction_shares": "1000",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2247"
    },
    {
      "id": 214399,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2023-10-13",
      "transaction_shares": "1000",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2247"
    },
    {
      "id": 160200,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-10-02",
      "transaction_shares": "1038",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20841"
    },
    {
      "id": 214385,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2023-10-02",
      "transaction_shares": "1038",
      "transaction_price": "372.46",
      "transaction_type": "M",
      "shares_after_transaction": "20841"
    }
  ]
}